Product Detail

Current Location: Home> Cytokines & Growth Factors>Interleukins>Y06501 Recombinant Human IL-13
Y06501 Recombinant Human IL-13

Synonym: Y06501 Recombinant Human Interleukin-13

Species: Human

Protein Accession: Y06501

Purity: >95%

Endotoxin Level: <1.0 EU per 1 μg of IL-13

Biological Activity: The ED50 for this effect is typically 0.5-2 ng/mL. Measured in a cell proliferation assay using TF-1 human erythroleukemic cells.

Expression System: Escherichia coli

Fusion Tag: His Tag

Predicted Molecular Mass: Approximately 12 kDa

Formulation: Lyophilized from a 0.2 μm filtered solution in PBS

Reconstitution: Reconstitute the lyophilized recombinant human IL-13 (Y06501) to a concentration of 0.1-1.0 mg/mL in sterile distilled water

Storage & Stability: Store lyophilized protein at -20°C. Aliquot the product after reconstitution to avoid repeated freezing/thawing cycles. Reconstituted protein can be stored at 4°C for a limited period of time.

FAQ

What is Y06501 Recombinant Human IL-13 and how does it benefit the feed industry?

Y06501 Recombinant Human IL-13 is a bioengineered protein that emulates the natural human interleukin-13 (IL-13). In the feed industry, this protein can be harnessed to modulate immune responses in livestock, ultimately improving animal health and productivity. By enhancing the immune system, animals can better resist diseases, reduce the need for antibiotics, and ensure a healthier growth environment. IL-13 is known for its role in immune regulation, reducing inflammation and promoting tissue repair. Incorporating Y06501 Recombinant Human IL-13 in feed can help achieve more resilient livestock, potentially leading to higher yields and improved feed conversion ratios. This means that animals can convert feed into body mass more efficiently, translating into better weight gain and overall growth performance.

How does Y06501 Recombinant Human IL-13 contribute to reducing antibiotic usage in livestock?

The incorporation of Y06501 Recombinant Human IL-13 in animal feed helps to bolster the immune system, making animals more resistant to infections. A robust immune system decreases the likelihood of disease outbreaks, reducing the reliance on antibiotics for disease prevention and treatment. By creating healthier livestock through immune modulation, producers can minimize the prevalence of antibiotic resistance—a significant concern in the industry today. As animals become less prone to infections due to the enhanced immune response facilitated by IL-13, the necessity for routine antibiotic use diminishes. This aligns with global efforts to reduce antibiotic use in livestock, promoting more sustainable and responsible farming practices.

Can Y06501 Recombinant Human IL-13 impact growth performance and feed efficiency in livestock?

Yes, Y06501 Recombinant Human IL-13 can positively affect growth performance and feed efficiency. By improving the overall health and immune status of livestock, animals can allocate more energy towards growth rather than fighting off diseases. Enhanced immune function and reduced inflammation contribute to better nutrient utilization, leading to improved feed conversion ratios. This means that animals can grow faster and more efficiently using the same amount of feed, optimizing productivity. Therefore, the use of Y06501 Recombinant Human IL-13 in feed formulations can result in higher weight gains, better feed efficiency, and potentially reduced feeding costs.

What are the potential environmental benefits of using Y06501 Recombinant Human IL-13 in livestock feed?

Utilizing Y06501 Recombinant Human IL-13 in livestock feed can have several environmental benefits. Improved feed efficiency means that animals require less feed to achieve the same growth, resulting in lower overall feed consumption. This not only reduces the demand for agricultural crops used in animal feed but also decreases the associated environmental footprint, including land use, water use, and greenhouse gas emissions. Additionally, healthier animals with stronger immune systems produce less waste and have fewer disease outbreaks, which can reduce environmental contamination from veterinary medicines and disease management practices. Thus, the integration of Y06501 can contribute to more sustainable and environmentally friendly livestock production systems.

Are there any specific livestock species that benefit more from Y06501 Recombinant Human IL-13?

Y06501 Recombinant Human IL-13 can be beneficial across various livestock species, including poultry, swine, and cattle. However, the specific impact may vary depending on the species and their unique immune system dynamics. For instance, poultry, which often face challenges related to respiratory and gastrointestinal diseases, may experience significant health improvements and better growth performance with the inclusion of IL-13. Swine, susceptible to various infectious diseases during different production stages, can also benefit from enhanced immune modulation. Similarly, cattle, particularly dairy and beef cattle, can see improvements in overall health, milk production, and meat quality. Therefore, while Y06501 is broadly beneficial, the particular advantages may be more pronounced in certain species depending on their specific health challenges and production systems.

Jiangsu East-Mab Biomedical Technology Co.,Ltd

contact us

Factory address:
Life and Health Industrial Park, Rudong County, Nantong City, Jiangsu Province

Contact: Fred Wang
Tel: 0086-25-52397805
Phone/WhatsApp: 0086-18005193850

mobile
Jiangsu East-Mab Biomedical Technology Co.,Ltd

Copyright(C)2023,Jiangsu East-Mab Biomedical Technology Co.,Ltd All Rights Reserved.

Leave A Message
Leave A Message ×
If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.